Literature DB >> 23487391

Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.

Abeer Moanna1, David Rimland.   

Abstract

We evaluated the effect of highly active antiretroviral therapy (HAART) on the incidence of herpes zoster (HZ) in human immunodeficiency virus (HIV)-infected subjects. The annual incidence of HZ per 100 person-years decreased significantly from 6.3 episodes in 1987 to 1.0 episode in 2011, probably reflecting improved immune function.

Entities:  

Keywords:  HAART era; HIV infection; herpes zoster; pre-HAART era; zoster vaccine

Mesh：

Substances：

Year:  2013        PMID： 23487391     DOI： 10.1093/cid/cit165

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  20 in total

1.  Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.

Authors:  Kosuke Kawai; Claudia A Hawkins; Ellen Hertzmark; Joel M Francis; David Sando; Aisa N Muya; Nzovu Ulenga; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

Review 2.  A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.

Authors:  Tehmina Bharucha; Damien Ming; Judith Breuer
Journal:  Hum Vaccin Immunother       Date:  2017-04-20       Impact factor: 3.452

Review 3.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

4.  [Diagnostics and management of herpes zoster ophthalmicus].

Authors:  R N Werner; N-I Steinhorst; A Nast; U Pleyer
Journal:  Ophthalmologe       Date:  2017-10       Impact factor: 1.059

5.  Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV.

Authors:  Kristine M Erlandson; Amber Streifel; Alexander R Novin; Kellie L Hawkins; Clayton Foster; Jacob Langness; Mary Bessesen; Julian Falutz; Abeer Moanna; David Looney; Scott T Johns; Joseph B Nguyen; Michael N Oxman; Myron J Levin
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-21       Impact factor: 2.205

6.  Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.

Authors:  Kellie L Hawkins; Kirsha S Gordon; Myron J Levin; Adriana Weinberg; Catherine Battaglia; Maria C Rodriguez-Barradas; Sheldon T Brown; David Rimland; Amy Justice; Janet Tate; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  Herpes Zoster in the Older Adult.

Authors:  Amrita R John; David H Canaday
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

9.  Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.

Authors:  Susannah L McKay; Angela Guo; Steven A Pergam; Kathleen Dooling
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 10.  Incidence of Herpes Zoster in HIV-Infected Patients Undergoing Antiretroviral Therapy: A Systematic Review and Meta-analysis.

Authors:  Han-Chang Ku; Yi-Tseng Tsai; Sriyani-Padmalatha Konara-Mudiyanselage; Yi-Lin Wu; Tsung Yu; Nai-Ying Ko
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.